Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1995 Sep;96(3):1664–1671. doi: 10.1172/JCI118207

Alcohol intake modulates the effect of a polymorphism of the cholesteryl ester transfer protein gene on plasma high density lipoprotein and the risk of myocardial infarction.

F Fumeron 1, D Betoulle 1, G Luc 1, I Behague 1, S Ricard 1, O Poirier 1, R Jemaa 1, A Evans 1, D Arveiler 1, P Marques-Vidal 1, et al.
PMCID: PMC185794  PMID: 7657837

Abstract

A polymorphism of the CETP gene (CETP/TaqIB) with two alleles B1 (60%) and B2 (40%) has been investigated in relation to lipid variables and the risk of myocardial infarction in a large case-control study (ECTIM) of men aged 25-64. No association was observed between the polymorphism and LDL or VLDL related lipid variables. Conversely, B2 carriers had reduced levels of plasma CETP (P < 0.0001) and increased levels of HDL cholesterol (P < 0.0001) and of other HDL related lipid variables. The effects of the polymorphism on plasma CETP and HDL cholesterol were independent, suggesting the presence of at least two functional variants linked to B2. A search for these variants on the coding sequence of the CETP gene failed to identify them. The effect of B2 on plasma HDL cholesterol was absent in subjects drinking < 25 grams/d of alcohol but increased commensurably, with higher values of alcohol consumption (interaction: P < 0.0001). A similar interaction was not observed for plasma CETP. The odds-ratio for myocardial infarction of B2 homozygotes decreased from 1.0 in nondrinkers to 0.34 in those drinking 75 grams/d or more. These results provide the first demonstration of a gene-environment interaction affecting HDL cholesterol levels and coronary heart disease risk.

Full text

PDF
1664

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Belfrage P., Berg B., Hägerstrand I., Nilsson-Ehle P., Tornqvist H., Wiebe T. Alterations of lipid metabolism in healthy volunteers during long-term ethanol intake. Eur J Clin Invest. 1977 Apr;7(2):127–131. doi: 10.1111/j.1365-2362.1977.tb01584.x. [DOI] [PubMed] [Google Scholar]
  2. Bhatnagar D., Durrington P. N., Channon K. M., Prais H., Mackness M. I. Increased transfer of cholesteryl esters from high density lipoproteins to low density and very low density lipoproteins in patients with angiographic evidence of coronary artery disease. Atherosclerosis. 1993 Jan 4;98(1):25–32. doi: 10.1016/0021-9150(93)90220-o. [DOI] [PubMed] [Google Scholar]
  3. Brown M. L., Inazu A., Hesler C. B., Agellon L. B., Mann C., Whitlock M. E., Marcel Y. L., Milne R. W., Koizumi J., Mabuchi H. Molecular basis of lipid transfer protein deficiency in a family with increased high-density lipoproteins. Nature. 1989 Nov 23;342(6248):448–451. doi: 10.1038/342448a0. [DOI] [PubMed] [Google Scholar]
  4. Cheung M. C., Wolf A. C., Lum K. D., Tollefson J. H., Albers J. J. Distribution and localization of lecithin:cholesterol acyltransferase and cholesteryl ester transfer activity in A-I-containing lipoproteins. J Lipid Res. 1986 Nov;27(11):1135–1144. [PubMed] [Google Scholar]
  5. DiLella A. G., Huang W. M., Woo S. L. Screening for phenylketonuria mutations by DNA amplification with the polymerase chain reaction. Lancet. 1988 Mar 5;1(8584):497–499. doi: 10.1016/s0140-6736(88)91295-0. [DOI] [PubMed] [Google Scholar]
  6. Freeman D. J., Griffin B. A., Holmes A. P., Lindsay G. M., Gaffney D., Packard C. J., Shepherd J. Regulation of plasma HDL cholesterol and subfraction distribution by genetic and environmental factors. Associations between the TaqI B RFLP in the CETP gene and smoking and obesity. Arterioscler Thromb. 1994 Mar;14(3):336–344. doi: 10.1161/01.atv.14.3.336. [DOI] [PubMed] [Google Scholar]
  7. Freeman D. J., Packard C. J., Shepherd J., Gaffney D. Polymorphisms in the gene coding for cholesteryl ester transfer protein are related to plasma high-density lipoprotein cholesterol and transfer protein activity. Clin Sci (Lond) 1990 Dec;79(6):575–581. doi: 10.1042/cs0790575. [DOI] [PubMed] [Google Scholar]
  8. Fruchart J. C., Ailhaud G. Apolipoprotein A-containing lipoprotein particles: physiological role, quantification, and clinical significance. Clin Chem. 1992 Jun;38(6):793–797. [PubMed] [Google Scholar]
  9. Gordon D. J., Probstfield J. L., Garrison R. J., Neaton J. D., Castelli W. P., Knoke J. D., Jacobs D. R., Jr, Bangdiwala S., Tyroler H. A. High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation. 1989 Jan;79(1):8–15. doi: 10.1161/01.cir.79.1.8. [DOI] [PubMed] [Google Scholar]
  10. Gordon D. J., Rifkind B. M. High-density lipoprotein--the clinical implications of recent studies. N Engl J Med. 1989 Nov 9;321(19):1311–1316. doi: 10.1056/NEJM198911093211907. [DOI] [PubMed] [Google Scholar]
  11. Hagiage M., Marti C., Rigaud D., Senault C., Fumeron F., Apfelbaum M., Girard-Globa A. Effect of a moderate alcohol intake on the lipoproteins of normotriglyceridemic obese subjects compared with normoponderal controls. Metabolism. 1992 Aug;41(8):856–861. doi: 10.1016/0026-0495(92)90167-9. [DOI] [PubMed] [Google Scholar]
  12. Hannuksela M. L., Liinamaa M. J., Kesäniemi Y. A., Savolainen M. J. Relation of polymorphisms in the cholesteryl ester transfer protein gene to transfer protein activity and plasma lipoprotein levels in alcohol drinkers. Atherosclerosis. 1994 Sep 30;110(1):35–44. doi: 10.1016/0021-9150(94)90065-5. [DOI] [PubMed] [Google Scholar]
  13. Hannuksela M., Marcel Y. L., Kesäniemi Y. A., Savolainen M. J. Reduction in the concentration and activity of plasma cholesteryl ester transfer protein by alcohol. J Lipid Res. 1992 May;33(5):737–744. [PubMed] [Google Scholar]
  14. Inazu A., Brown M. L., Hesler C. B., Agellon L. B., Koizumi J., Takata K., Maruhama Y., Mabuchi H., Tall A. R. Increased high-density lipoprotein levels caused by a common cholesteryl-ester transfer protein gene mutation. N Engl J Med. 1990 Nov 1;323(18):1234–1238. doi: 10.1056/NEJM199011013231803. [DOI] [PubMed] [Google Scholar]
  15. Inazu A., Jiang X. C., Haraki T., Yagi K., Kamon N., Koizumi J., Mabuchi H., Takeda R., Takata K., Moriyama Y. Genetic cholesteryl ester transfer protein deficiency caused by two prevalent mutations as a major determinant of increased levels of high density lipoprotein cholesterol. J Clin Invest. 1994 Nov;94(5):1872–1882. doi: 10.1172/JCI117537. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Jiang X. C., Agellon L. B., Walsh A., Breslow J. L., Tall A. Dietary cholesterol increases transcription of the human cholesteryl ester transfer protein gene in transgenic mice. Dependence on natural flanking sequences. J Clin Invest. 1992 Oct;90(4):1290–1295. doi: 10.1172/JCI115993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Jiang X. C., Moulin P., Quinet E., Goldberg I. J., Yacoub L. K., Agellon L. B., Compton D., Schnitzer-Polokoff R., Tall A. R. Mammalian adipose tissue and muscle are major sources of lipid transfer protein mRNA. J Biol Chem. 1991 Mar 5;266(7):4631–4639. [PubMed] [Google Scholar]
  18. Kondo I., Berg K., Drayna D., Lawn R. DNA polymorphism at the locus for human cholesteryl ester transfer protein (CETP) is associated with high density lipoprotein cholesterol and apolipoprotein levels. Clin Genet. 1989 Jan;35(1):49–56. doi: 10.1111/j.1399-0004.1989.tb02904.x. [DOI] [PubMed] [Google Scholar]
  19. Langer R. D., Criqui M. H., Reed D. M. Lipoproteins and blood pressure as biological pathways for effect of moderate alcohol consumption on coronary heart disease. Circulation. 1992 Mar;85(3):910–915. doi: 10.1161/01.cir.85.3.910. [DOI] [PubMed] [Google Scholar]
  20. Mendis S., Shepherd J., Packard C. J., Gaffney D. Genetic variation in the cholesteryl ester transfer protein and apolipoprotein A-I genes and its relation to coronary heart disease in a Sri Lankan population. Atherosclerosis. 1990 Jul;83(1):21–27. doi: 10.1016/0021-9150(90)90126-4. [DOI] [PubMed] [Google Scholar]
  21. Mezdour H., Kora I., Parra H. J., Tartar A., Marcel Y. L., Fruchart J. C. Two-site enzyme immunoassay of cholesteryl ester transfer protein with monoclonal and oligoclonal antibodies. Clin Chem. 1994 Apr;40(4):593–597. [PubMed] [Google Scholar]
  22. Orita M., Iwahana H., Kanazawa H., Hayashi K., Sekiya T. Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. Proc Natl Acad Sci U S A. 1989 Apr;86(8):2766–2770. doi: 10.1073/pnas.86.8.2766. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Parra H. J., Arveiler D., Evans A. E., Cambou J. P., Amouyel P., Bingham A., McMaster D., Schaffer P., Douste-Blazy P., Luc G. A case-control study of lipoprotein particles in two populations at contrasting risk for coronary heart disease. The ECTIM Study. Arterioscler Thromb. 1992 Jun;12(6):701–707. doi: 10.1161/01.atv.12.6.701. [DOI] [PubMed] [Google Scholar]
  24. Saiki R. K., Gelfand D. H., Stoffel S., Scharf S. J., Higuchi R., Horn G. T., Mullis K. B., Erlich H. A. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science. 1988 Jan 29;239(4839):487–491. doi: 10.1126/science.2448875. [DOI] [PubMed] [Google Scholar]
  25. Sanger F., Nicklen S., Coulson A. R. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A. 1977 Dec;74(12):5463–5467. doi: 10.1073/pnas.74.12.5463. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Savolainen M. J., Hannuksela M., Seppänen S., Kervinen K., Kesäniemi Y. A. Increased high-density lipoprotein cholesterol concentration in alcoholics is related to low cholesteryl ester transfer protein activity. Eur J Clin Invest. 1990 Dec;20(6):593–599. doi: 10.1111/j.1365-2362.1990.tb01906.x. [DOI] [PubMed] [Google Scholar]
  27. Takahashi K., Jiang X. C., Sakai N., Yamashita S., Hirano K., Bujo H., Yamazaki H., Kusunoki J., Miura T., Kussie P. A missense mutation in the cholesteryl ester transfer protein gene with possible dominant effects on plasma high density lipoproteins. J Clin Invest. 1993 Oct;92(4):2060–2064. doi: 10.1172/JCI116802. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Tall A. R. Plasma cholesteryl ester transfer protein. J Lipid Res. 1993 Aug;34(8):1255–1274. [PubMed] [Google Scholar]
  29. Taskinen M. R., Välimäki M., Nikkilä E. A., Kuusi T., Ehnholm C., Ylikahri R. High density lipoprotein subfractions and postheparin plasma lipases in alcoholic men before and after ethanol withdrawal. Metabolism. 1982 Nov;31(11):1168–1174. doi: 10.1016/0026-0495(82)90169-x. [DOI] [PubMed] [Google Scholar]
  30. Tenkanen H., Koshinen P., Kontula K., Aalto-Setälä K., Mänttäri M., Manninen V., Runeberg S. L., Taskinen M. R., Ehnholm C. Polymorphisms of the gene encoding cholesterol ester transfer protein and serum lipoprotein levels in subjects with and without coronary heart disease. Hum Genet. 1991 Sep;87(5):574–578. doi: 10.1007/BF00209015. [DOI] [PubMed] [Google Scholar]
  31. Välimäki M., Kahri J., Laitinen K., Lahdenperä S., Kuusi T., Ehnholm C., Jauhiainen M., Bard J. M., Fruchart J. C., Taskinen M. R. High density lipoprotein subfractions, apolipoprotein A-I containing lipoproteins, lipoprotein (a), and cholesterol ester transfer protein activity in alcoholic women before and after ethanol withdrawal. Eur J Clin Invest. 1993 Jul;23(7):406–417. doi: 10.1111/j.1365-2362.1993.tb00783.x. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES